New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

Needham analyst Michael Matson maintained a Hold rating on Boston Scientific (BSX – Research Report) today. The company’s shares closed ...

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of ...

For the current quarter ending in March, Boston Scientific expects its per-share earnings to range from 66 cents to 68 cents. The company expects full-year earnings in the range of $2.80 to $2.87 per ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

Canaccord Genuity maintained its Buy rating on Boston Scientific (NYSE:BSX) shares and increased the price target to $117 from $101. The adjustment follows the company's robust fourth-quarter earnings ...

Boston Dynamics and the RAI Institute are joining forces to teach the humanoid robot Atlas new tasks more quickly.

Boston Celtics vs. Cleveland Cavaliers in the NBA starts at 7:30 p.m. ET on Feb. 4. This game takes place at Rocket Mortgage ...

Boston Micro Fabrication (BMF), a leader in advanced manufacturing solutions for ultra-high precision applications, announced ...